| # | Drug | Count |
|---|---|---|
| 0 | FINASTERIDE | 5 |
| 1 | GADOBUTROL | 3 |
| 2 | GADOBENATE DIMEGLUMINE | 2 |
| 3 | IBUPFROFEN | 2 |
| 4 | IBUPROFEN | 2 |
| 5 | IBUPROFEN 200 MG | 2 |
| 6 | IBUPROFEN 200MG | 2 |
| 7 | IBUPROFEN CAPSULE | 2 |
| 8 | IBUPROFEN CAPSULES 200 MG | 2 |
| 9 | IBUPROFEN ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GADOBUTROL | 3 | 0.0006 |
| 1 | GADOBENATE DIMEGLUMINE | 2 | 0.0005 |
| 2 | SOLRIAMFETOL | 1 | 0.0003 |
| 3 | METHIMAZOLE | 1 | 0.0001 |
| 4 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 1 | 0.0001 |
| 5 | FINASTERIDE | 5 | 0.0001 |
| 6 | MODAFINIL | 1 | 0.0000 |
| 7 | IRON | 2 | 0.0000 |
| 8 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 1 | 0.0000 |
| 9 | CYCLOBENZAPRINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Gadolinium-based Contrast Agent [EPC] | 3 | 0.0006 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 5 | 0.0000 |
| 4 | Sympathomimetic-like Agent [EPC] | 1 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |